A Platform to Identify Antifungal Compounds with Novel Action Mechanisms
Award amount
$300,156Program and phase
SBIR · Phase IAward year
2023Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INTACT GENOMICS INC
- Proposal award date
- 2023-07-19
- Contract end date
- 2024-06-30
- UEI
- ZR9GABSXHMY8
- Solicitation number
- PA22-176
- Topic code
- R43
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes
- Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool
- Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool
- A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans
- Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Discovery of antiviral inhibitors for the treatment of orthopoxvirus infections
- Capturing Health Information from Research Ontologies (CHIRON)
- Transcutaneous auricular neurostimulation for neonatal abstinence syndrome
- Remote vital sign and opioid overdose detection via a non-invasive wearable sensing patch
- Probe Development for Histone Demethylase Networks
Research funding history
11 SBIR/STTR records share this UEI (2014–2023). Reported award amounts total $12,430,364. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services